Science Explorer Back to mapMap
Discussion
Researcher · Centre Hospitalier de Versailles · France

Sophie Rigaudeau

Sophie Rigaudeau publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0002-9639-9305 OpenAlex
World rank
#1,167,232
of 7,710,434 ranked researchers
Rank in France
#53,934
of 324,115
Works
78
Citations
1.5k
Citations per work
19.2
h-index
19
i10-index 30Top 26% in Hematology
Sophie Rigaudeau

What does Sophie Rigaudeau research?

Sophie Rigaudeau's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 49 works · 62.5% of their workMedicine: 49 works · 62.5% of their workHematology: 20 works · 25.2% of their workOncology: 12 works · 15.0% of their workInfectious Diseases: 8 works · 10.2% of their workGenetics: 5 works · 6.3% of their workPublic Health, Environmental and Occupational Health: 5 works · 5.8% of their workEverything else: 17 works · 22.0% of their workLife Sciences: 12 works · 15.5% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 15.5% of their workMolecular Biology: 12 works · 15.5% of their workTHEIR WORKSophie Rigaudeau78works
Life Sciences16%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4962.5%
  2. Everything else1722.0%
    1. Biochemistry, Genetics and Molecular Biology1215.5%
  1. 1Hematology25% of their works
  2. 2Molecular Biology16% of their works
  3. 3Oncology15% of their works
  4. 4Infectious Diseases10% of their works
  5. 5Genetics6% of their works
  6. 6Public Health, Environmental and Occupational Health6% of their works

Research topics

Which keywords describe Sophie Rigaudeau's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, BET Bromodomains, PROTACs, Chronic Lymphocytic Leukemia, Genomic Aberrations and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Diagnosis Criteria371 topic
  2. International Myeloma Working Group371 topic
  3. Prognostic Factors212 topics
  4. BET Bromodomains131 topic
  5. PROTACs131 topic
  6. Chronic Lymphocytic Leukemia121 topic
  7. Genomic Aberrations121 topic
  8. AML91 topic
  9. Acute Myeloid Leukemia91 topic
  10. Chemotherapy-Induced Peripheral Neuropathy91 topic
  11. Taxanes91 topic
  12. Ebola Virus61 topic
  13. Fibroblast Activation Protein61 topic
  14. Outbreak61 topic
  15. Tumor Microenvironment61 topic
  16. BCR-ABL51 topic
  17. Imatinib51 topic

Where does Sophie Rigaudeau work?

Sophie Rigaudeau's main affiliation in the publication record is Centre Hospitalier de Versailles, France.

How many publications and citations does Sophie Rigaudeau have?

OpenAlex counts 78 works and 1,499 citations for Sophie Rigaudeau, an h-index of 19, ranking #1,167,232 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sophie Rigaudeau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.